Detalhe da pesquisa
1.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110735
2.
Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cells.
Mol Ther
; 31(8): 2309-2325, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312454
3.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477542
4.
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.
N Engl J Med
; 377(26): 2545-2554, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29226764
5.
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy.
Immunol Cell Biol
; 92(6): 475-80, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24732076
6.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.
Nat Cancer
; 5(3): 517-531, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216766
7.
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.
Cancer Discov
; 13(9): 1982-1997, 2023 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249512
8.
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.
Blood Cancer Discov
; 4(2): 118-133, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413381
9.
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia.
Blood Adv
; 6(21): 5774-5785, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349631
10.
Monitoring of tisagenlecleucel transgene DNA using a quantitative polymerase chain reaction assay.
Mol Ther Methods Clin Dev
; 20: 535-541, 2021 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33614827
11.
An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity.
Cell Chem Biol
; 28(6): 802-812.e6, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333026
12.
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
J Clin Oncol
; 39(27): 3044-3055, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156874
13.
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells.
Nat Med
; 27(5): 842-850, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888899
14.
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.
J Clin Invest
; 129(6): 2210-2221, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30896447
15.
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
Nat Med
; 24(10): 1504-1506, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30275569
16.
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 24(5): 563-571, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713085
17.
Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ.
J Clin Invest
; 110(10): 1441-8, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12438442
18.
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.
Sci Transl Med
; 9(399)2017 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724573
19.
Rationale for anti-GITR cancer immunotherapy.
Eur J Cancer
; 67: 1-10, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591414
20.
An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity.
Cell Chem Biol
; 28(4): 583, 2021 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33861956